(Q28141864)

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Neurokinin receptor gene expression in substantia nigra: localization, regulation, and potential physiological significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Substance P and Parkinson's disease: a causal relationship?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Substance P and neurodegenerative disorders. A speculative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Tachykinins, neurotrophism and neurodegenerative diseases: a critical review on the possible role of tachykinins in the aetiology of CNS diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

An NK1 receptor antagonist affects the circadian regulation of locomotor activity in golden hamsters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Pharmacological characterization and autoradiographic localization of substance P receptors in guinea pig brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

A comparative autoradiographic study of the distributions of substance P and eledoisin binding sites in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Behavioural effects of tachykinins and related peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Modulation of the rat mesolimbic dopamine pathway by neurokinins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Expression of substance P receptor in the substantia nigra.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Multiple mechanisms of arachidonic acid release in Chinese hamster ovary cells transfected with cDNA of substance P receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Pharmacological properties of a potent and selective nonpeptide substance P antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Molecular cloning of substance P receptor cDNA from guinea-pig uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Tachykinin receptor types: Classification and membrane signalling mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Mismatches between neurotransmitter and receptor localizations in brain: observations and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Molecular characterization of a functional cDNA encoding the rat substance P receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Pharmacological profiles of new orally active nonpeptide tachykinin NK1 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Capsaicin induced release of multiple tachykinins (substance P, neurokinin A and eledoisin-like material) from guinea-pig spinal cord and ureter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

A structural rationale for the design of water soluble peptide-derived neurokinin-1 antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Substance P is involved in the sensitization of the acoustic startle response by footshocks in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Highly potent substance P antagonists substituted with beta-phenyl- or beta-benzyl-proline at position 10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Multiple tachykinin binding sites in peripheral tissues and in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Substance P enhances NMDA channel function in hippocampal dentate gyrus granule cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Intranigral stimulation of oral movements by [Pro9] substance P, a neurokinin-1 receptor agonist, is enhanced in chronically neuroleptic-treated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Polypeptide-containing neurons in airway smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

A substance P antagonist inhibits heat-induced oedema in the rat skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Regulation of substance P receptor affinity by guanine nucleotide-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Chemical cross-linking of the substance P (NK-1) receptor to the alpha subunits of the G proteins Gq and G11

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Tachykinins as peripheral modulators of primary afferent nerves and visceral sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

The dual nature of the tachykinin NK1 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Tachykinin receptors and tachykinin receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Differential increases of neurokinin B- and enkephalin-like immunoreactivities and their mRNAs after chronic haloperidol treatment in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Increased synthesis of neurokinin B and enkephalin after chronic haloperidol treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Nonpeptide antagonists of the NK1 tachykinin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Multiple intracellular signaling pathways of the neuropeptide substance P receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Neurotransmitter functions of mammalian tachykinins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Further evidence that central tachykinin NK-1 receptors mediate the inhibitory effect of tachykinins on angiotensin-induced drinking in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

The tachykinin NK1 receptor. Part I: Ligands and mechanisms of cellular activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

The nonpeptide NK-1 receptor antagonists LY303870 and LY306740 block the responses of spinal dorsal horn neurons to substance P and to peripheral noxious stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Pharmacology of neurokinin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Pharmacological receptors for substance P and neurokinins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Receptors for substance P and related neurokinins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Simultaneous release of several tachykinins and calcitonin gene-related peptide from rat spinal cord slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Different behavioral profiles of the non-peptide substance P (NK-1) antagonists CP-96,345 and RP 67580

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Thapsigargin blocks the mobilisation of intracellular calcium caused by activation of human NK1 (long) receptors expressed in Chinese hamster ovary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Evidence that substance P is utilized in medial amygdaloid facilitation of defensive rage behavior in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Immunocytochemical localization of rat substance P receptor in the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Pharmacological characterization of grooming induced by a selective NK-1 tachykinin receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Molecular cloning of the murine substance K and substance P receptor genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Ligand Binding Kinetics of Substance P and Neurokinin A Receptors Stably Expressed in Chinese Hamster Ovary Cells and Evidence for Differential Stimulation of Inositol 1,4,5‐Trisphosphate and Cyclic AMP Second Messenger Responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Drug treatment of chemotherapy-induced delayed emesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Neurokinin-1 receptor antagonist SR140333: a novel type of drug to treat cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

The substance P (NK1) receptor antagonist (±)-CP-96,345 causes sedation and motor impairment in Swiss albino mice in the black-and-white box behavioral paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

Different behavioral profiles of the non-peptide substance P (NK1) antagonists CP-96,345 and RP 67580 in Swiss albino mice in the black-and-white box.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900259-9

10.1016/S0014-2999(99)00259-9

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

3539245

3539245

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference